These findings reveal a previously unrecognizedrole for PTP1B in regulating the immunogenicity of tumor cell deathand suggest that targeting PTP1B may offer a promising strategy toenhance the efficacy of cancer chemoimmunotherapy. This evidence concerns the gene PTPN1 and cancer.